Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.85 | ||
| Change(%) | ![]() | +0.04 | |
| Volume | 651943 | ||
| 3:26 PM - Mar 09, 2010 | |||
News
Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Present at BMO Focus on Healthcare Conference
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon Reports Solid Third Quarter 2008 Results
-- Provides update on the sale of the specialty pharma business --
Enzon to Release First Quarter 2008 Earnings on Wednesday, May 7, 2008; Conference Call and Webcast to Follow
Enzon's PEG-SN38 Featured in Clinical Cancer Research

Enzon Stockholders Approve Company Proposals at 2009 Annual Meeting
Enzon to Purchase a Portion of its Outstanding Debt
Enzon's HIF-1 alpha Antagonist Shows Antitumor Activity
--Innovative and diverse pipeline advances--
Enzon Pharmaceuticals to Add New Independent Director to Board
